Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Temferon by Genenta Science for Supratentorial Glioma: Likelihood of Approval
Temferon is under clinical development by Genenta Science and currently in Phase II for Supratentorial Glioma. According to GlobalData, Phase...